Sildenafil Citrate

Click image to view original image
Brand: yc
型号: 171599-83-0
规格: USP
Price: 10.00USD/g
Min.Order: 10 g
Supply 5000 g
Delivery: Shipment within 3 days since the date of payment
Address: China
Valid until: Never Expire
Updated on: 2015-04-27 10:11
Hits: 880222
Buy
Company Detail
 
 
Details
Viagra Muscle Gain Steroids Source Sildenafil Citrate 98% 171599-83-0 for Sex Enhancer
Quick Details:
Product name: Sildenafil Citrate 
Synonyms:Sildenafil citrate; viagra; 
CAS Registry Number:171599-83-0 
Assay:98% 
MF:C28H38N6O11S 
MW:666.7 
Melting point 187-189°C 
Appearance:White Solid 
Usage:An orally active selective type 5 cGMP phosphodiesterase inhibitor 
Biological Activity :Orally active, potent inhibitor of phosphodiesterase 5 (PDE5) (IC 50 = 4 nM). Enhances nitric oxide-dependent relaxation of human corpus cavernosum in vitro. 
Other drugs in same class:Anastrozole,Letrozole,Tamoxifen citrate,Exemestane 
Product Description:
Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It was originally discovered by Pfizer scientists Andrew Bell, David Brown, and Nicholas Terrett. 
Application:
The primary indication of sildenafil is treatment of erectile dysfunction (inability to sustain a satisfactory erection to complete intercourse). Its use is now standard treatment for erectile dysfunction in all settings, including diabetes.
In clinical trials, the most common adverse effects of sildenafil use included headache, flushing, dyspepsia, nasal congestion and impaired vision, including photophobia and blurred vision.Some sildenafil users have complained of seeing everything tinted blue (cyanopsia).Some complained of blurriness and loss of peripheral vision. In July 2005, the FDA found that sildenafil could lead to vision impairment in rare cases and a number of studies have linked sildenafil use with nonarteritic anterior ischemic optic neuropathy.
Rare but serious adverse effects found through postmarketing surveillance include priapism, severe hypotension, myocardial infarction (heart attack), ventricular arrhythmias, stroke, increased intraocular pressure, and sudden hearing loss. As a result of these postmarketing reports, in October 2007, the FDA announced that the labeling for all PDE5 inhibitors, including sildenafil, required a more prominent warning of the potential risk of sudden hearing loss.
Competitive Advantages:
1. Sufficient Stock, to deliver goods within 12 hours after receiving the payment;
2. Professional Packing Team, discreet ways of packing for Customs pass guarantee;
3. Untracable Payment Options, the tracking number will be provided every other day;
4. Good After-sale Service, any of the problems will receive our prompt attention.
Total: 0 [Show All]  Related Reviews
 
More »Our Others Products

[ ProductsSearch ]  [ Add To Favourite ]  [ Tell Friends ]  [ Print Content ]  [ Violation Report ]  [ Close Window ]